Idiopathic interstitial pneumonia: peculiarities of clinical picture and treatment


Cite item

Full Text

Abstract

Idiopathic interstitial pneumonias (IIP) combine several diseases from the group of interstitial lung disease characterized by many similar signs: unknown etiology, progressive exertional breathlessness, diffuse lesions on the lung X-ray and CT, and restrictive ventilatory insufficiency. However, these diseases have a sufficient number of differences (primarily morphological; approach to therapy and prognosis), to consider each of the forms of IIP as separate nosological entity. Modern ATS/ERS classification includes seven forms of IIP, the most common of which are discussed in this article.

About the authors

S N Avdeev

S N Avdeev

References

  1. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2002;165:277-304.
  2. American Thoracic Society. Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment. International Consensus Statement. Am J Respir Crit Care Med 2000;161:646-64.
  3. Raghu G, Weycker D, Edelsberg J, et al. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006;174:810-16.
  4. Baumgartner KB, Samet J, Stidley CA, et al. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1997;155:242-48.
  5. Baumgartner KB, Samet JM, Coultas DB, et al. Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case control study. Am J Epidemiol 2000;152:307-15.
  6. Tobin RW, Pope CE, Pellegrini CA, et al. Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998;158:1804-08.
  7. British Thoracic Society recommendations. The diagnosis, assessment and treatment of diffuse parenchymal disease in adults. Thorax 1999;54(Suppl.1):S1-S30.
  8. Johnston IDA, Prescott RJ, Chalmers JC, et al. British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Thorax 1997;52:38-44.
  9. Alhamad EH, Lynch JP, Martinez FJ. Pulmonary function in interstitial lung disease: what role do they have? Clin Chest Med 2001:715-50.
  10. Pipavath S, Godwin JD. Imaging of interstitial lung disease. Radiol Clin N Am 2005;43:589-99.
  11. Corrin B. Pathology of interstitial lung diseases. Semin Resp Crit Care Med 1994;15:61-76.
  12. Daniels CE, Ryu JH. Treatment of idiopathic pulmonary fibrosis. Semin Respir Crit Care Med 2006;27:668-76.
  13. Azuma A, Nukiwa T, Tsuboi E, et al. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2005;171:1040-47.
  14. King TE, Behr J, Brown KK, et al. BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2008;177:75-81.
  15. Demedts M, Behr J, Buhl R, et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2005;353:2229-42.
  16. Katzenstein AL, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 1994;18:136-47.
  17. Flaherty KR, Martinez FJ. Nonspecific interstitial pneumonia. Semin Respir Crit Care Med 2006;27:652-58.
  18. Cottin V, Donsbeck AV, Revel D, et al. Nonspecific interstitial pneumonia. Individualization of a clinicopathologic entity in a series of 12 patients. Am J Respir Crit Care Med 1998;158:1286-93.
  19. Shimizu S, Yoshinouchi T, Ohtsuki Y, et al. The appearance of S-100 protein-positive dendritic cells and the distribution of lymphocyte subsets in idiopathic nonspecific interstitial pneumonia. Respir Med 2002;96:770-76.
  20. Daniil ZD, Gilchrist FC, Nicholson AG, et al. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 1999;160:899-905.
  21. Watanabe K, Higuchi K, Ninomiya K, et al. Steroid treatment based on the findings of transbronchial biopsy in idiopathic interstitial pneumonia. Eur Respir J 2002;20:1213-19.
  22. Drent M, du Bois RM, Poletti V. Recent advances in the diagnosis and management of nonspecific interstitial pneumonia. Curr Opin Pulm Med 2003;9:411-17.
  23. Davison AG, Heard BE, McAllister WAC, et al. Cryptogenic organizing pneumonitis. Q J Med 1983;52:382-94.
  24. Epler GR, Colby TV, McLoud TC, et al. Bronchiolitis obliterans organizing pneumonia. N Engl J Med 1985;312:152-58.
  25. Muller N, Muller R. Diseases of the bronchioles: CT and histopathologic findings. Radiology 1995;196:3-12.
  26. Cordier J-F. Cryptogenic organising pneumonia. Eur Respir J 2006;28:422-46.
  27. Lazor R, Vandevenne A, Pelletier A, et al. Cryptogenic organizing pneumonia: characteristics of relapses in a series of 48 patients. Am J Respir Crit Care Med 2000;162:571-77.
  28. Nagai S, Kitaichi M, Itoh H, et al. Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J 1998;12:1010-19.
  29. Cohen AJ, King TE, Downey GP. Rapidly progressive bronchiolitis obliterans with organizing pneumonia. Am J Respir Crit Care Med 1994;149:1670-75.
  30. Liebow AA, Steer A, Billingsley JG. Desquamative interstitial pneumonia. Am J Med 1965;39:369-404.
  31. Katzenstein AL, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998;157:1301-15.
  32. Carrington CB, Gaensler EA, Coutu RE, et al. Usual and desquamative interstitial pneumonia. Chest 1976;69:261-63.
  33. Ryu JH, Myers JL, Capizzi SA, et al. Desquamative interstitial pneumonia and respiratory bronchiolitis-associated interstitial lung disease. Chest 2005;127:178-84.
  34. Hartman TE, Primack SL, Swensen SJ, et al. Desquamative interstitial pneumonia: thin-section CT findings in 22 patients. Radiology 1993;187:787-90.
  35. Hamman L, Rich AR. Fulminating diffuse interstitial fibrosis of the lungs. Trans Am Clin Climat Assoc 1935;51:154-63.
  36. Askin FB. Back to the future: The Hamman-Rich syndrome and acute interstitial pneumonia. Mayo Clin Proc 1990;65:1624-26.
  37. Olson J, Colby TV, Elliott CG. Hamman-Rich syndrome revisited. Mayo Clin Proc 1990;65:1538-48.
  38. Bouros D, Nicholson AC, Polychronopoulos V, et al. Acute interstitial pneumonia. Eur Respir J 2000;15:412-18.
  39. Katzenstein AL, Myers JL, Mazur MT. Acute interstitial pneumonia: a clinicopathologic, ultrastructural, and cell kinetic study. Am J Surg Pathol 1986;10:256-67.
  40. Vourlekis JS, Brown KK, Cool CD, et al. Acute interstitial pneumonitis. Case series and review of the literature. Medicine (Baltimore) 2000;79:369-78.
  41. Ichikado K, Johkoh T, Ikezoe J, et al. Acute interstitial pneumonia: high-resolution CT findings correlated with pathology. Am J Roentgenol 1997;168:333-38.
  42. Johkoh T, Muller NL, Taniguchi H, et al. Acute interstitial pneumonia: Thin-section CT findings in 36 patients. Radiology 1999;211:859-63.
  43. http://www.pharmateca.ru/cgi-bin/statyi.pl?sid=2462&mid=1085056570&magid=183

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2009 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies